FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
Background. Gastric cancer is the second leading cause of cancer-related death due to advanced disease. A special role in the pathogenesis and metastasis of the tumor is assigned to tumor stem cells (TSC ), responsible for resistance to chemotherapy and radiotherapy and causing tumor progression.Ob...
Main Authors: | A. B. Sagakyants, O. I. Kit, E. P. Ulyanova, E. Yu. Zlatnik, I. A. Novikova, O. G. Shulgina, Yu. A. Gevorkyan, N. V. Soldatkina, N. S. Samoylenko, E. A. Dzhenkova, A. V. Shaposhnikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2021-03-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1696 |
Similar Items
-
The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
by: Peng Jiang, et al.
Published: (2024-04-01) -
Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01) -
Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
by: Aseel Kamil Mohammed Al-mosawi, et al.
Published: (2020-04-01) -
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
by: Xiaomei Gao, et al.
Published: (2018-07-01) -
Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer
by: Zahran AM, et al.
Published: (2019-02-01)